Valuation: NanoRepro AG

Market Cap 20.18M 22.6M 18.64M 16.9M 31.61M 2.15B 32.13M 224M 88.82M 1.12B 84.81M 83.01M 3.54B P/E 2026 *
-12.3x
P/E 2027 * -40x
Enterprise Value 17.02M 19.06M 15.72M 14.25M 26.66M 1.81B 27.1M 189M 74.91M 948M 71.53M 70.01M 2.99B EV / Sales 2026 *
0.93x
EV / Sales 2027 * 0.78x
Free-Float
85.93%
Yield 2026 *
-
Yield 2027 * -
1 day-2.74%
1 week-7.25%
1 month-6.98%
3 months-23.81%
6 months+3.56%
Current year+6.31%
1 week 1.58
Extreme 1.58
1.78
1 month 1.55
Extreme 1.55
1.8
Current year 1.31
Extreme 1.31
2.4
1 year 1.31
Extreme 1.31
2.4
3 years 1.16
Extreme 1.165
2.4
5 years 1.16
Extreme 1.165
10.44
10 years 0.4
Extreme 0.4
22.4
Manager TitleAgeSince
Chief Executive Officer - 2013-03-31
Director of Finance/CFO - 2020-12-31
Sales & Marketing - -
Director TitleAgeSince
Chairman 49 2012-12-31
Director/Board Member - 2023-06-14
Director/Board Member 49 2023-06-14
Date Insider Type Main position Quantity % Market Cap. Importance
8/4/23 Buy

Chief Executive Officer

20,000 0.1550%
5/17/23 Buy

Chief Executive Officer

5,000 0.0387%
5/17/23 Buy

Chief Executive Officer

20,000 0.1550%
Change 5-day change 1-year change 3-year change Capi.($)
-2.74%-7.25%-3.90%-30.43% 22.6M
+1.16%-1.13%-18.25%+9.38% 179B
+0.02%+4.24%-19.55%+15.88% 118B
-1.22%+0.70%+1.86%+32.59% 117B
+2.29%+17.36%-42.18%+8.22% 93.26B
-2.21%-2.91%-0.51%+75.12% 63.16B
-1.06%+1.75%+13.48%+74.12% 55.68B
-0.75%+3.73%+7.04%-23.26% 54.18B
-1.13%+0.00%-12.56%+30.09% 44.15B
+0.17%+5.85%-5.20%-11.43% 33.95B
Average -0.55%+2.52%-7.98%+18.03% 75.85B
Weighted average by Cap. -0.00%+3.09%-11.77%+21.99%

Financials

2026 *2027 *
Net sales 18.4M 20.6M 17M 15.4M 28.82M 1.96B 29.3M 205M 80.98M 1.02B 77.33M 75.68M 3.23B 24.75M 27.72M 22.86M 20.72M 38.76M 2.63B 39.41M 275M 109M 1.38B 104M 102M 4.35B
Net income -1.8M -2.02M -1.66M -1.51M -2.82M -191M -2.87M -20.01M -7.92M -100M -7.56M -7.4M -316M -500K -560K -462K -419K -783K -53.15M -796K -5.56M -2.2M -27.85M -2.1M -2.06M -87.8M
Net Debt -3.16M -3.54M -2.92M -2.65M -4.95M -336M -5.03M -35.13M -13.91M -176M -13.28M -13M -555M -915K -1.02M -845K -766K -1.43M -97.27M -1.46M -10.17M -4.03M -50.96M -3.85M -3.76M -161M
Projected Income Statement - Annual - NanoRepro AG
Logo NanoRepro AG
NanoRepro AG is a Germany-based healthcare and consumer health company specializing in the development, production, and distribution of rapid diagnostic products, as well as the marketing of dietary supplements. The company develops and markets its products through a portfolio of proprietary brands, including ZuhauseTEST for home diagnostics and rapid testing solutions, alphabiol for complementary products and nutritional supplements, PAEDIPROTECT for dermatologically tested baby skincare products, and newkee for skincare products for adults. Its product range includes a variety of self-testing solutions, such as COVID-19, pregnancy, gastric health, fertility, and allergy tests, along with colorectal cancer screening tests.
Employees
22
Date Price Change Volume
26-10-23 €1.600 -2.74% 12,600
26-10-22 €1.645 -3.80% 2,306
26-10-21 €1.710 -3.93% 1,472
26-10-20 €1.780 +2.01% 1,853
26-10-19 €1.745 +1.16% 150
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - NanoRepro AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.600EUR
Average target price
4.475EUR
Spread / Average Target
+179.69%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - NanoRepro AG